Fund Evaluator:
Eaton Vance Worldwide Health Sci R (ERHSX)
Follow This Fund
Best Performing in Health Over the Last Year
| 67.1% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 66.9% | Fidelity Advisor Biotechnology I (FBTIX) |
| 58.0% | Fidelity Select Biotechnology (FBIOX) |
| 54.2% | Rydex Biotechnology Inv (RYOIX) |
| 49.7% | Eventide Healthcare & Life Sciences N (ETNHX) |
Fund Details
Eaton Vance Worldwide Health Sci R Overview
Eaton Vance Worldwide Health Sci R (ERHSX) is an actively managed Sector Equity Health fund. Eaton Vance launched the fund in 2003.
The investment seeks long-term capital growth by investing in a worldwide and diversified portfolio of health sciences companies. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It has a policy of investing at least 25% of its assets in investments in the medical research and health care industry.
About Eaton Vance Worldwide Health Sci R (ERHSX)
There are 2 members of the management team with an average tenure of 10.17 years: Jason Kritzer (2016), Samantha Pandolfi (2016). Management tenure is more important for actively managed funds than passive index funds.
The fund has 2 primary benchmarks: MSCI World NR USD index with a weighting of 100% and MSCI World/Healthcare NR USD index with a weighting of 100%. Eaton Vance Worldwide Health Sci R has 41 securities in its portfolio. The top 10 holdings constitute 60.1% of the fund’s assets. The fund meets the SEC requirement of being classified as a diversified fund. The fund is not considered to have an ESG focus with its investment selection and management.
Eaton Vance Worldwide Health Sci R is part of the Equity global asset class and is within the Sector Equity fund group. Eaton Vance Worldwide Health Sci R has 24.3% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 75.7%. There is 24.3% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). Eaton Vance Worldwide Health Sci R has 0.0% of the portfolio in cash.
Assets Under Management
The fund has $51 million in total assets, which is below the $907 million average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
ERHSX Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The Eaton Vance Worldwide Health Sci R expense ratio is high compared to funds in the Health category. Eaton Vance Worldwide Health Sci R has an expense ratio of 1.43%, which is 18% higher than its category average, making the fund expense ratio grade a D. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. Eaton Vance Worldwide Health Sci R has a portfolio turnover rate of 30%, indicating that holds its assets around 0.0 years. By way of comparison, the average portfolio turnover is 62% for the Health category.
Recently, in the month of August 2026, Eaton Vance Worldwide Health Sci R returned 3.4%, which earned it a grade of F, as the Health category had an average return of 5.0%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all funds in that category.
Eaton Vance Worldwide Health Sci R has a trailing yield of 0.20%, which is below the 0.37% category average. The fund normally distributes its income annually and its capital gains annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
Eaton Vance Worldwide Health Sci R Grades
Year to date, the fund has returned 3.3%, 9.2 percentage points worse than the category, which translates into a grade of F. The fund has returned 14.1% over the past year (grade of F), 6.1% over the past three years (grade of F) and 3.1% per year over the past five years (grade of D) and 8.1% per year over the past 10 years (grade of F).
For more mutual fund grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about Eaton Vance Worldwide Health Sci R, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
ERHSX Trailing NAV Total Returns Data as of 8/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| ERHSX Return (NAV) | 3.4% | 10.1% | 14.1% | 6.1% | 3.1% | 8.1% |
| ERHSX Grade | F | F | F | F | D | F |
| +/- Category | -1.6% | -3.4% | -18.8% | -6.9% | -2.2% | -2.1% |
| Health Avg | 5.0% | 13.4% | 32.9% | 13.1% | 5.2% | 10.2% |
| ERHSX Tax Cost Ratio | na | na | 1.5% | 1.0% | 1.2% | 1.3% |
ERHSX Annual NAV Total ReturnsData as of 8/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| ERHSX Return (NAV) | 3.3% | 10.0% | 3.2% | 5.4% | -9.7% | 21.8% | 12.7% | 25.6% | 5.8% | 15.9% | -15.1% |
| ERHSX Grade | F | F | C | C | C | A | F | D | A | F | D |
| +/- Category | -9.2% | -10.6% | 0.7% | -0.1% | -0.3% | 13.1% | -11.7% | -2.8% | 5.5% | -7.5% | -4.2% |
| Health Avg | 12.5% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 13.6% |
| Total Risk Index: | 1.12 - Above Average |
| Category Risk Index: | 0.85 - Low |
| Category Risk Grade: | A (6% Rank) |
| Beta: | 0.56 |
| R-Squared: | 26% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Value |
| Bond Investment Style: | na |
| Yield: | 0.2% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $806 Mil |
| Fund Total Assets: | $ 51 Mil |
| Share Class Type: | Retirement |
| Portfolio Turnover: | 30% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 10.2 years | |||
| Average Tenure: 10.2 years | |||
| Managers (Year): Kritzer Jason (2016), Pandolfi Samantha (2016) | |||
Portfolio Composition (as of 6/30/26)
| # of Holdings: | 41 |
| % in Top 10 Holdings: | 60.1% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 24.3% |
Portfolio Allocation |
|
| Domestic Stock: | 75.7% |
| Foreign Stock: | 24.3% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.0% |
Purchase Information
| Fund Family: | Eaton Vance |
| Phone Number: | 800-262-1122 |
| Website: | www.eatonvance.com |
| Status: | Open |
| Inception Date: | September 8, 2003 |
| Min. Initial Purchase: | $1,000 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | No |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.50% |
Expenses and Fees | |
| Expense Ratio (%): | 1.43% ( Rating : High ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | Eaton Vance Worldwide Health Sci A |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
